在反馈环节，专家组对生殖医学中心的各项工作给予充分的肯定，尤其在该科室精细化管理、医疗质量持 续改进方面给予高度评价。专家组认为，在生育意愿和出生率持续下降的大环境下，生殖医学中心门诊量 及辅助生殖助孕周期数依然逐步上升，实属难得。同时，专家组就检查中发现的问题，以及中心下一步的 学科建设和发展规划，提出了中肯的建设性指导意见。 经过4个多小时的严谨校验检查，专家组一致认为，烟台山医院生殖医学中心开展的相关技术在两年运行周 期内管理和伦理制度落实到位，技术实施与掌握成熟，自查机制运行严格，各项主要技术指标均完全达到 相关技术规范要求，无违法违规情况，严格落实了国家和我省关于人类辅助生殖技术的相关要求。经无记 名投票，生殖医学中心以961分的高分(满分1000分)全票再次通过辅助生殖技术校验。 烟台山医院党委副书记衣振中表示，本次校验既是对医院生殖医学中心两年来工作的一次全面检阅和把脉 问诊，更是帮助医院进一步提升技术、规范管理、保障安全的宝贵契机。烟台山医院将高度重视、虚心听 取、认真落实各位专家的指导意见，持续推动生殖医学专业的规范化、高质量发展。校验中专家组对医院 工作的认可，既是荣誉，更是责任。未来烟台 ...

Core Viewpoint - The research from the Chinese Academy of Sciences introduces a 3D human embryo implantation model that replicates the entire process of embryo implantation, aiming to identify the causes of repeated implantation failure (RIF) in assisted reproductive technology [1][3]. Group 1: Research Findings - Approximately 10% of patients undergoing assisted reproductive technology experience clinical pregnancy failure after three embryo transfers, with factors such as embryo quality, endometrial condition, and immune response potentially contributing to this issue [1]. - The study reveals that RIF patients exhibit increased apoptotic cells and decreased proliferation ability in their endometrial cells, indicating a less favorable environment for embryo implantation [1]. - The implantation rates and subsequent development of embryos in RIF patients are significantly lower compared to healthy individuals, correlating with clinical observations of "successful transfers but embryo arrest" [1]. Group 2: Technological Advancements - The research team has validated that endometrial cells obtained from menstrual blood have a 94% similarity in gene expression to those from biopsy samples, allowing for the creation of an "artificial endometrium" with a variance of less than 5% in implantation rates [2]. - This non-invasive method of obtaining endometrial samples through menstrual blood significantly enhances patient acceptance compared to traditional biopsy methods that carry risks of bleeding and infection [2]. Group 3: Embryo-Maternal Interaction - The research elucidates the signaling interactions between the embryo and the endometrium during the attachment and invasion phases, identifying pathways that promote attachment site formation and inhibit epithelial cell apoptosis [3]. - Blocking these pathways can lead to a 68% decrease in blastocyst attachment rates, highlighting the critical nature of these interactions for successful implantation [3]. - The study also extends the simulation of embryo development to the post-implantation phase, allowing for the observation of whether the embryo is truly developing [3]. Group 4: Implications for Reproductive Medicine - The 3D embryo implantation simulation chip technology bridges basic research and clinical application, providing practical diagnostic tools for clinicians in reproductive medicine [3]. - The research team has tested 1,119 FDA-approved drugs, paving the way for personalized drug screening for patients, which could enhance the precision of assisted reproductive technologies [4]. - This advancement not only addresses implantation failure but also contributes to understanding early developmental abnormalities and pregnancy complications [4].

Core Viewpoint - The research from the Chinese Academy of Sciences has developed a 3D human embryo implantation model using microfluidic chips, which successfully replicates the entire process of human embryo implantation in the lab, potentially uncovering the causes of repeated implantation failure (RIF) in assisted reproductive technology [2][10]. Group 1: Simplified Detection Process - Approximately 10% of individuals undergoing assisted reproductive treatment experience clinical pregnancy failure after three embryo transfers, with factors such as embryo quality, endometrial condition, and immune system responses contributing to this issue [3]. - The new technology creates a simulated endometrial system to accurately identify the causes of implantation failure, revealing that RIF patients often have increased apoptotic cells and decreased proliferation ability in their endometrial cells, indicating a less favorable environment for embryo implantation [3][5]. Group 2: Observing Embryo Development - The research team has analyzed the signaling interactions between the embryo and the endometrium during the attachment and invasion stages, identifying pathways that promote attachment site formation and inhibit epithelial cell apoptosis [6][9]. - Blocking these pathways can lead to a 68% decrease in blastocyst attachment rates, highlighting the critical nature of these interactions for successful implantation [6]. Group 3: Efficient Drug Screening - The 3D embryo implantation simulation technology bridges basic research and clinical application, providing practical diagnostic tools for clinicians in the field of reproductive medicine [10]. - The research team has tested 1,119 FDA-approved drugs, paving the way for personalized drug screening for patients, which could enhance the precision of assisted reproductive technologies [12].